PROTEOSTASIS THERAPEUTICS, INC. Purchase Agreements
10 Contracts & Agreements
- Form of Amendment No. 6 to Securities Purchase Agreement, dated October 13, 2023 (Filed With SEC on October 17, 2023)
- Form of Securities Purchase Agreement, dated as of October 3, 2023 (Filed With SEC on October 5, 2023)
- Form of Amendment No. 5 to Securities Purchase Agreement, dated July 21, 2023 (Filed With SEC on July 21, 2023)
- Form of Amendment No. 4 to Securities Purchase Agreement, dated May 1, 2023 (Filed With SEC on June 2, 2023)
- Form of Securities Purchase Agreement, dated as of April 20, 2023 (Filed With SEC on April 21, 2023)
- Form of Amendment No. 2 to the Securities Purchase Agreement dated December 5, 2022 (Filed With SEC on December 5, 2022)
- Form of Securities Purchase Agreement Amendment, dated October 24, 2022 (Filed With SEC on October 24, 2022)
- Form of Securities Purchase Agreement, dated June 5, 2022, by each of the parties named therein (Filed With SEC on June 6, 2022)
- Asset Purchase Agreement, dated June 5, 2022, by and among Yumanity and Janssen (Filed With SEC on June 6, 2022)
- PROTEOSTASIS THERAPEUTICS, INC. 2016 EMPLOYEESTOCK PURCHASE PLAN (Filed With SEC on February 1, 2016)
